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reduction) CAD: 37 had single, 19 double and 24 triple vessel disease. Sen-
sitivity for detection of CAD was 78% for ECHO and 84% for MIBI (p = ns).
Specificity was 77% for ECHO and 91% for MIBI (p= ns). Overall accuracy
was 78Y0for ECHO and 85% for MIBI (p = ns). Intercanter variation in ac-
curacy ranged from 50% to 100% for ECHO (variation coefficient = 19.7)
and from 79% to 100% for MIBI (variation coefficient= 8.2). Angiographically
assessed extent and severity of CAD evaluated by the Duke score waa cor-
related to the extent and severity of both parfusion defects (each segment
scored from O= normal to 3 = absent tracer uptake) with MIBI (r= 0.55, p <
0.01) and functional impairment (each segment scored from O= normal to 3
= dyskinetic) by ECHO (r = 0.50, p < 0.01). In conclusion, MIBI and ECHO
have comparable accuracy for noninvasive identification of angiogrephicelly
assessed CAD during high dose dipytfdamole stress. InterCentervariability
in diagnostic accuracy is higher for ECHO than MIBI. Both methods allow
a reasonably accurate estimation of extent and aaverity of CAD through a
samiquantitetiva assessment of extent and severity of perfusion or functional
defects.
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We have previously demonstrated thatthe myocerdial uptake of TI-201 (TI)
more accurately tracks coronary flow during adenoaine (Ado) hyperemia
than either Tc-99m-sestamibi ortetrofosmin. NOET is a new Tc-99m-labeled
myocardial perfusion tracer which redistributes similar to T1.We compared
TI and NOET uptake in 9 dogs with either critical (n = 4) or mild (n = 5)
IAD stenoses after simultaneous injection with microsphere during Ado
infuaion (300 w@kg/min). As shown, 5 min after injection, NOET uptake by
gamma well counting was higher than TI overa wide range of flow. Although
both TI and NOET uptake underestimated the magnitude of flow disparity,
NOET more closely matched flow. The mean flow and tracer activity ratios
(LAD/LCX) were:
Group Flow -t-l NOET
Critical 0.14* 0.02 0.51i 0.05* 0.34i o.03*t *p< 0,01W Flow
Mild 0.53* 0.09 0.78h 0.07* 0,71* o.07*t tp <0,05 vsm
I
i- :
a 10s
!4
~ 90 122 2W 300 400 500 6W
Mwcwdld BloodS’bzw(%ol —o
Thus, NOET appears to be the firat Tc-99m-labslsd myocardial perfusion
tracer with myocadial retention higher than TI after 5 min. This finding,
combined with its redistribution property, suggest that NOET may be well
suited for pharmacologic stress imaging.
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The relationship between tracer uptake and myocardial blocd flow (MBF) for
multiple Tc-99m.labalad perfusion tracers has not been previously rapotied
uaing dobutemine, which is used to simulate axercise. Therefore, in an open
cheat canine modetofischemia (18 dogs), durfngdobutamine infusion, the ra-
Iationship between myocardial tracer uptake and MBF was characterized for
six tracers (TI-201, Tc99m-Q3, Tc99m-Q12, Tc99m-Q4, Tc99m-tetrofosmin
(Tetro),Tc99m-sestemibi (MIBI)).
Dobutamine effect was varifiad by a statistically significant increase in
dP/df and coronary flow, with no difference among tracer groups. The data
were combined after normalizing to the average tracer activity and MBF
for each dog. The relation between tracer uptake (% average) vs. MBF (%
average) wss analyzed by linear regression. The number of samples (n),
correlation coefficient (r), line alopa, and y intercept are presented in the
following tabla:
TL-201 Q3 Q4 Q12 Tetro MIBI
n 266 201 268 266 268 201
0.94 0.97 0.91 0.95 0.90 0.92
:Iope 0,64” 0.77’ 0.62”” 0.61*” 0.72;” 0.60*-
Intercept 0.16” 0.23” 0.39”” 0.39*” 0.32*- o.40*-
*p< 0,01 comparedto Q3; “p <0.01 compared to T1-201 by ANOVA,
In conclusion, the flow vs. uptake characteristics of Tc99m-Q3 and T1-201
during dobutamine infusion are superior to the remaining tracers.
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Animal experiments have shown ‘gmTc-Tetrofosmin(Tetro)to reach a plateau
of myocerdialextraction with increasing corona~ blood flow rates atan aarlier
stage than .201Thallium (Th). Tharefore, the detection of mild coronawartery
stenoaes might be superior with Dipyrfdamole (DP) Th than DP-Tatro. We
conducted a randomized trial in 21 consecutive patients with angiographicelly
demonstrated corona~ artety disease using SPECT DP-Th vs SPECT DP-
Tetro. Quantitative coronary angiography was employed to aasess severity
of vessel stanoaes. A total number of 19 mild coronary artery stenosea (50-
70%), 19 severa stenoses (71-99%) and 10 total occlusions waa identified.
SPECT DP-Th revealed a perfusion defect in 13 (88%) of 19 territories
patfused by vessels with mild stenoses (10 were reversible). SPECT DP-
Tetro identified 7 (37%) defects in the sama 19 territories (3 wera reversible;
one sided T-teat for reversible defects, p = 0.05; two-sided p = 0.1). DP-Th
and DP-Tetro identified an equal number of defects in areas perfused by
coronary arteries with severe stenoaes or total occlusions (76% and 72%).
Conclusion: Though only with a marginal statistical difference, SPECT DP-
Th detects more reversible perfusion defects in mild corona~ artery diseaae
than DP-Tetro.Thedetaction rate for defects interritorias perfused byveaeels
with severe stenosas is similar.
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The purpose waatoassassthe clinical efficacy and safety of intravenous (iv.)
dofetilide, a new selactive potassium channel blocker, in acute termination
of atrial fibrillation (AF) and fluttar (AFI). Ninety-eight patients with AF/AFl
of a duration from ona hour to six months prior to screening were randomly
allocated to receiva a doaa of dofetilide 8 p~kg or placebo infused iv. over
a period of 30 minutea. Respondera were defined as patiants convening to
sinus rhythm within three hours after the start of infusion.
Resu/ts:Sixty-seven patients received dofetilide and 31 received placebo.
The two groups had comparable baseline characteristics. Nineteen (28.4%)
patients receiving dofetilide and one (3.2%) patient receiving placebo re-
sponded to treatment (p = 0.005). Pre-study mean duration of AF/AFl was
68 + 80 days for responders varsus 75 + 51 days for non-respondera (p ‘
= 0.54). Two patiants (3%) developad toreade de pointes ventricular tachy-
cerdia (TdPVT) in relation to dofetilide infusion. Prior to the occurrence of
TdPVT, infusion of dofetilide was prematurely tanminateddue to gross distor-
tion of T-wave morphology. Both TdPVT-patients were successfully treated
with magnesium chloride iv.. The occurrence of proarrhythmia wee not asso-
ciated to dofetilide plasma concentration. No other cardiac or extra-cardiac
side effects were noted.
Conclusions: Intravenous dofetilide 8 @kg over~ minutes is effective in
acute termination of AF/AFl. The incidence of proarrhythmia ia comparable
to what has been observed with other antiarrhythmic agents.
